NCT06988319 - Psilocybin for Chronic Pelvic Pain (CPP) in Women: A Pilot Feasibility Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 1, 2026

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Chronic Pelvic Pain

Interventions

DRUG

Psilocybin (Usona Institute)

Single dose of pharmaceutical grade psilocybin (25 mg) combined with psychotherapy sessions

Trial Locations (1)

Oregon Health & Science University, Portland

All Listed Sponsors

collaborator

Portland Psychotherapy Clinic, Research, and Training Center

OTHER

lead

Oregon Health and Science University

OTHER